Ramzan Firyal, McPhail Mike, Rao Pengcheng, Mo Kaiguo, Halievski Katherine, Swift-Gallant Ashlyn, Mendoza-Viveros Lucia, Cheng Hai-Ying M, Monks D Ashley
Department of Psychology.
Institute of Medical Sciences, University of Toronto, Mississauga, Ontario L5L 1C6, Canada.
J Neurosci. 2015 Apr 22;35(16):6444-51. doi: 10.1523/JNEUROSCI.3599-14.2015.
Polyglutamine (polyQ) expansion of the androgen receptor (AR) causes Kennedy's disease/spinobulbar muscular atrophy (KD/SBMA) through poorly defined cellular mechanisms. Although KD/SBMA has been thought of as a motor neuron disease, recent evidence indicates a key role for skeletal muscle. To resolve which early aspects of the disease can be caused by neurogenic or myogenic mechanisms, we made use of the tet-On and Cre-loxP genetic systems to selectively and acutely express polyQ AR in either motor neurons (NeuroAR) or myocytes (MyoAR) of transgenic mice. After 4 weeks of transgene induction in adulthood, deficits in gross motor function were seen in NeuroAR mice, but not MyoAR mice. Conversely, reduced size of fast glycolytic fibers and alterations in expression of candidate genes were observed only in MyoAR mice. Both NeuroAR and MyoAR mice exhibited reduced oxidative capacity in skeletal muscles, as well as a shift in fast fibers from oxidative to glycolytic. Markers of oxidative stress were increased in the muscle of NeuroAR mice and were reduced in motor neurons of both NeuroAR and MyoAR mice. Despite secondary pathology in skeletal muscle and behavioral deficits, no pathological signs were observed in motor neurons of NeuroAR mice, possibly due to relatively low levels of polyQ AR expression. These results indicate that polyQ AR in motor neurons can produce secondary pathology in muscle. Results also support both neurogenic and myogenic contributions of polyQ AR to several acute aspects of pathology and provide further evidence for disordered cellular respiration in KD/SBMA skeletal muscle.
雄激素受体(AR)的聚谷氨酰胺(polyQ)扩展通过尚不明确的细胞机制导致肯尼迪病/脊髓延髓肌萎缩症(KD/SBMA)。尽管KD/SBMA一直被认为是一种运动神经元疾病,但最近的证据表明骨骼肌起着关键作用。为了确定该疾病的哪些早期方面可由神经源性或肌源性机制引起,我们利用四环素调控(tet-On)和Cre-loxP基因系统在转基因小鼠的运动神经元(NeuroAR)或肌细胞(MyoAR)中选择性且急性地表达polyQ AR。成年期转基因诱导4周后,NeuroAR小鼠出现总体运动功能缺陷,而MyoAR小鼠未出现。相反,仅在MyoAR小鼠中观察到快速糖酵解纤维尺寸减小以及候选基因表达改变。NeuroAR和MyoAR小鼠的骨骼肌氧化能力均降低,同时快速纤维从氧化型向糖酵解型转变。氧化应激标志物在NeuroAR小鼠的肌肉中增加,而在NeuroAR和MyoAR小鼠的运动神经元中均减少。尽管骨骼肌存在继发性病理改变和行为缺陷,但NeuroAR小鼠的运动神经元未观察到病理迹象,这可能是由于polyQ AR表达水平相对较低。这些结果表明运动神经元中的polyQ AR可在肌肉中产生继发性病理改变。结果还支持了polyQ AR对病理多个急性方面的神经源性和肌源性作用,并为KD/SBMA骨骼肌细胞呼吸紊乱提供了进一步证据。